Flexible ligand docking using conformational ensembles
By D. Lorber, Brian K. Shoichet. 1998
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Ryan G. Coleman
- Brian K. Shoichet
- Teague Sterling
- John J. Irwin
- Michael Carchia
- Yu Chen
- Michael M. Mysinger
- Anastasiia V. Sadybekov
Citations in the corpus
- Molecular docking: a powerful approach for structure-based drug discovery. (2011, methodology): “For VS, 235,000 commercially available molecules were docked into the crystal structure of PTP-1B (PDB code 1pty) using the Northwestern University version [134-137] of DOCK3.”
- Computational approaches streamlining drug discovery (2023, methodology): “The docking procedure itself can use molecular mechanics, often in internal coordinate representation, for rapid conformational sampling of fully flexible ligands 52,53 , using empirical 3D shape-matching approaches 54,55 , or combining them in a hybrid docking funnel 56,57 .”
- Exploiting drug-disease relationships for computational drug repositioning (2011, unknown): “atomic and molecular interactions [31].”
- Molecular docking and ligand specificity in fragment-based inhibitor discovery (2009, methodology): “Spheres were labeled for chemical matching based on the hydrogen bonding properties and ionization states of nearby protein atom”
- Database Screening for HIV Protease Ligands: The Influence of Binding-Site Conformation and Representation on Ligand Selectivity (1999, background): “However, when screening databases, DOCK typically keeps the ligands rigid, or docks a set of rigid conformers for each compound (Lorber & Shoichet 1998; Shoichet, Leach, & Kuntz 1999).”